Axovant Sciences Ltd. Contracts & Agreements

Plan of Complete Liquidation and Dissolution of Sio Gene Therapies Inc (Filed With SEC on December 14, 2022)

Employment Agreement, dated (Filed With SEC on June 14, 2022)

Form of Indemnification Agreement with directors and executive officers (Filed With SEC on June 14, 2022)

Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on November 12, 2021)

Description of Securities (Filed With SEC on June 9, 2021)

Form of Pre-funded Warrant to purchase Shares of Common Stock (Filed With SEC on June 9, 2021)

Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on June 9, 2021)

Sales Agreement, dated as of December 16, 2020, between Sio Gene Therapies Inc. and SVB Leerink LLC (Filed With SEC on December 18, 2020)

Form of Common Stock Certificate (Filed With SEC on November 13, 2020)

Sales Agreement, dated as of April 29, 2020, between Axovant Gene Therapies Ltd. and SVB Leerink LLC (Filed With SEC on April 29, 2020)

Underwriting Agreement, dated February 19, 2020 (Filed With SEC on February 21, 2020)

Form of Pre-Funded Warrant to purchase Common Shares (Filed With SEC on February 21, 2020)

Third Amendment to Loan and Security Agreement, dated November 27, 2019, by and among Axovant Gene Therapies Ltd., Axovant Holdings Limited, Axovant Sciences GmbH, Axovant... (Filed With SEC on December 3, 2019)

Employment Agreement, dated November 4, 2019, by and between Pavan Cheruvu and Axovant Sciences, Inc (Filed With SEC on November 8, 2019)

Employment Agreement, dated November 4, 2019, by and between David Nassif and Axovant Sciences, Inc (Filed With SEC on November 8, 2019)

Employment Agreement, dated November 4, 2019, by and between Gavin Corcoran and Axovant Sciences, Inc (Filed With SEC on November 8, 2019)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2015 Equity Incentive Plan, as amended (Filed With SEC on September 24, 2019)

Separation and General Release Agreement between Axovant Sciences, Inc. and Gregory Weinhoff, M.D., dated June 28, 2019 (Filed With SEC on August 9, 2019)

Separation and General Release Agreement between Axovant Sciences, Inc. and Mathew Bazley, dated July 29, 2019 (Filed With SEC on August 9, 2019)

Separation and General Release Agreement between Axovant Sciences, Inc. and Mark Altmeyer, dated March 16, 2019 (Filed With SEC on June 11, 2019)

Amended and Restated Services Agreement, effective as of June 10, 2019, by and among Roivant Sciences, Inc., Axovant Sciences GmbH, Axovant Sciences, Inc. and the Registrant (Filed With SEC on June 11, 2019)

Amended and Restated Services Agreement, effective as of June 10, 2019, by and among Roivant Sciences GmbH and Axovant Sciences GmbH (Filed With SEC on June 11, 2019)

Underwriting Agreement, dated March 13, 2019 (Filed With SEC on March 15, 2019)

Exclusive License Agreement, dated as of December 7, 2018, by and between the Registrant and the University of Massachusetts (Filed With SEC on February 7, 2019)

Underwriting Agreement, dated December 14, 2018, between Axovant Sciences Ltd. and Jefferies LLC, as representative of the several underwriters named therein (Filed With SEC on December 17, 2018)

License Agreement, dated as of July 9, 2018, by and between the Registrant and Benitec Biopharma Limited (Filed With SEC on November 7, 2018)

Amendment No. 1, dated July 23, 2018, to the License Agreement, dated as of July 9, 2018, by and between the Registrant and Benitec Biopharma Limited (Filed With SEC on November 7, 2018)

Amended and Restated Information Sharing and Cooperation Agreement, dated as of June 5, 2018, by and between the Registrant and Roivant Sciences Ltd (Filed With SEC on August 7, 2018)

Share Purchase Agreement, dated as of June 5, 2018, by and between the Registrant and Roivant Sciences Ltd (Filed With SEC on August 7, 2018)

License Agreement, dated as of June 5, 2018, by and between the Registrant and Oxford BioMedica (UK) Ltd (Filed With SEC on August 7, 2018)

Sales Agreement, dated as of June 22, 2018, between Axovant Sciences Ltd. and Cowen and Company, LLC (Filed With SEC on June 22, 2018)

Separation Agreement, dated February 7, 2018, by and between Marion McCourt and Axovant Sciences, Inc (Filed With SEC on June 11, 2018)

Separation Agreement, dated February 11, 2018, by and between David Hung and Axovant Sciences, Inc (Filed With SEC on June 11, 2018)

Mutual Release Agreement, dated February 11, 2018, by and between David Hung and Axovant Sciences, Inc (Filed With SEC on June 11, 2018)

Employment Agreement, dated February 13, 2018, by and between Pavan Cheruvu and Axovant Sciences, Inc (Filed With SEC on June 11, 2018)

Second Amendment to Loan and Security Agreement, dated September 22, 2017, by and among the Registrant, Axovant Holdings Limited, Axovant Sciences GmbH, Axovant Sciences, Inc.,... (Filed With SEC on November 2, 2017)

Letter Agreement, dated October 18, 2017, re: Non-Commercial Manufacturing Provisions of the Development, Marketing and Supply Agreement, dated May 8, 2015, by and between Arena... (Filed With SEC on November 2, 2017)

AXOVANT SCIENCES LTD. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 18, 2015 APPROVED BY THE SOLE MEMBER: MARCH 18, 2015 AMENDED BY THE BOARD OF DIRECTORS:... (Filed With SEC on August 22, 2017)

AXOVANT SCIENCES LTD. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on June 13, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on June 13, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 13, 2017)

6,742,179 Common Shares Axovant Sciences Ltd. UNDERWRITING AGREEMENT (Filed With SEC on April 13, 2017)

AXOVANT SCIENCES, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2017)

AMENDED AND RESTATED SERVICES AGREEMENT (Filed With SEC on February 14, 2017)

SERVICES AGREEMENT (Filed With SEC on February 14, 2017)

WARRANT AGREEMENT to Purchase Common Shares of AXOVANT SCIENCES LTD. Dated as of February 2, 2017 (the Effective Date) (Filed With SEC on February 3, 2017)

AXOVANT SCIENCES LTD. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on June 6, 2016)

AMENDED AND RESTATED SERVICES AGREEMENT (Filed With SEC on February 9, 2016)

Development, Marketing and Supply Agreement by and between Arena Pharmaceuticals GmbH and Roivant Sciences Ltd. dated May 8, 2015 (Filed With SEC on February 9, 2016)

[ ] Common Shares Axovant Sciences Ltd. UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2015)

Axovant Sciences Ltd. Clarendon House, 2 Church Street, Hamilton HM11 Bermuda axovant.com (Filed With SEC on June 1, 2015)

AXOVANT SCIENCES LTD. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 18, 2015 APPROVED BY THE SOLE MEMBER: MARCH 18, 2015 AMENDED BY THE BOARD OF DIRECTORS:... (Filed With SEC on May 22, 2015)

AXOVANT SCIENCES LTD. STOCK OPTION GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on May 22, 2015)

AXOVANT SCIENCES LTD. EARLY EXERCISE STOCK PURCHASE AGREEMENT UNDER THE 2015 EQUITY INCENTIVE PLAN (Filed With SEC on May 22, 2015)

AXOVANT SCIENCES LTD. INDEMNIFICATION AGREEMENT (Filed With SEC on May 22, 2015)

AXOVANT SCIENCES, INC. EMPLOYMENT AGREEMENT (Filed With SEC on May 22, 2015)

Axovant Sciences, Inc. 1441 Broadway, 3rd Floor, New York, NY 10018 axovant.com (Filed With SEC on May 22, 2015)

WAIVER AND OPTION AGREEMENT (Filed With SEC on May 22, 2015)

ASSET PURCHASE AGREEMENT Between GLAXO GROUP LIMITED and GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED and ROIVANT NEUROSCIENCES LTD. Dated as of December 17, 2014 (Filed With SEC on May 11, 2015)

SERVICES AGREEMENT (Filed With SEC on May 11, 2015)

INFORMATION SHARING AND COOPERATION AGREEMENT (Filed With SEC on May 11, 2015)

Category

Industry

Companies

Contracts

Axovant Sciences Ltd. Contracts & Agreements